|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: LUMINEX CORP, 10-Q, 2000-11-13 |
Next: DELTAGEN INC, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 15,542
<SECURITIES> 61,319
<RECEIVABLES> 2,223
<ALLOWANCES> 139
<INVENTORY> 1,237
<CURRENT-ASSETS> 81,780
<PP&E> 4,202
<DEPRECIATION> 1,670
<TOTAL-ASSETS> 84,351
<CURRENT-LIABILITIES> 1,774
<BONDS> 0
0
0
<COMMON> 27
<OTHER-SE> 81,204
<TOTAL-LIABILITY-AND-EQUITY> 84,351
<SALES> 4,974
<TOTAL-REVENUES> 5,099
<CGS> 3,124
<TOTAL-COSTS> 3,124
<OTHER-EXPENSES> 6,025<F1>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (8,985)
<INCOME-TAX> 0
<INCOME-CONTINUING> (8,985)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,985)
<EPS-BASIC> (0.40)
<EPS-DILUTED> (0.40)
<FN>
<F1>Items consist of research & development.
</FN>
</TABLE>
|
|